Study S000040

A Phase I, Single-blinded, Randomized, Multiple Dose, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Different Dose Escalation Schemes of BI 456906 in Healthy Japanese Male Subject With BMI 23-40 kg/m2

ClinicalTrials.gov record

Registration

Registration: NCT04384081
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: SINGLE
Status: COMPLETED
Enrollment: 37
Start: 2020-06-01
Primary completion: 2020-11-17
Lead sponsor: Boehringer Ingelheim
Conditions: Healthy
Interventions: DRUG:BI 456906; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Cumulative percentage (%) of subjects withdrawn from up-titration by dose escalation scheme. [up to 113 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.